Takeda Pharmaceutical - Primary Care Product Assets - Ownership and Business Overview

Life ScienceCompany

Takeda Pharmaceutical - Primary Care Product Assets Ownership

Who owns Takeda Pharmaceutical - Primary Care Product Assets?

Takeda Pharmaceutical - Primary Care Product Assets is owned by Celltrion. It was acquired on November 30, 2020.

Takeda Pharmaceutical - Primary Care Product Assets Business Overview

Where is Takeda Pharmaceutical - Primary Care Product Assets headquartered?

Takeda Pharmaceutical - Primary Care Product Assets is headquartered in Osaka, Japan.

What sector is Takeda Pharmaceutical - Primary Care Product Assets in?

Takeda Pharmaceutical - Primary Care Product Assets is a life science company.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Join Mergr to view all 285 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 262 by strategics.

Takeda Pharmaceutical Co.,Ltd. - Primary Care (PC) Product Assets

Osaka, 103-8668
Japan,

Takeda Pharmaceutical Co. Ltd. - Primary Care 18 products include prescription medicines such as Nesina (diabetes), Actos (diabetes), and Edarbi (hypertension) which were developed for the global market, as well as OTC (Over-the-counter) products well known to consumers such as Whituben (cold remedy). Nesina and Edarbi.


Company Summary

SECTOR

Life Science

 Subscribe to unlock this and 207,877
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Takeda Pharmaceutical - Primary Care Product Assets

Life Science Companies , Japan Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for Japan Companies

Largest Japan Companies , Acquisitive Japan Companies , Recently Acquired Japan Companies , Recently Sold Japan Companies , Private Japan Companies , Public Japan Companies , Acquired Japan Companies , PE Backed Japan Companies
Mergr

Product

Company

Legal